Compare GBX & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBX | LMRI |
|---|---|---|
| Founded | 1974 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | 2025 |
| Metric | GBX | LMRI |
|---|---|---|
| Price | $46.46 | $18.21 |
| Analyst Decision | Sell | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $50.67 | N/A |
| AVG Volume (30 Days) | 334.5K | ★ 1.4M |
| Earning Date | 01-08-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ 27.96 | N/A |
| EPS | ★ 6.35 | N/A |
| Revenue | ★ $3,240,200,000.00 | $1,003,375,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.33 | ★ N/A |
| Revenue Growth | N/A | ★ 1.38 |
| 52 Week Low | $37.77 | $15.81 |
| 52 Week High | $71.06 | $19.45 |
| Indicator | GBX | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | N/A |
| Support Level | $46.02 | N/A |
| Resistance Level | $47.03 | N/A |
| Average True Range (ATR) | 1.02 | 0.00 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 41.90 | 0.00 |
Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.